According to Dr. Margaret Chan, director general of the World Health Organization, common infections could be fatal as bacteria develop in equivocating antibiotics.
Chan noted in a statement at a conference in Copenhagen that antibiotic resistance could lead to “the end of modern medicine as we know it.”
“We are losing our first-line antimicrobials,” she said Wednesday in her keynote address at the conference on combating antimicrobial resistance. “Replacement treatments are more costly, more toxic, need much longer durations of treatment, and may require treatment in intensive care units.”
Diseases that were once easily be treated, like tuberculosis, are now becoming more difficult to cure and cost much higher to treat.
According to Chan, the utility if multidrug resistant tuberculosis was “extremely complicated typically requiring two years of medication with toxic and expensive medicines, some of which are in constant short supply. Even with the best of care, only slightly more than 50 percent of these patients will be cured.”
Experts also have found out the antibiotic-resistant strains of salmonella, gonorrhoea and E. coli.
Some experts say that they are withdrawing to the pre-antibiotic era, but according to Chan, the situation seem like we are drawing to post-antibiotic era. “In terms of new replacement antibiotics, the pipeline is virtually dry,” said Chan. “A post-antibiotic era means, in effect, an end to modern medicine as we know it. Things as common as strep throat or a child’s scratched knee could once again kill,” she Chan Added.
The shortage of effective antibiotics could higher the risk of surgical procedures and cancer treatments or, worst, impossible to treat, she said.
In a threatening result, some of the complicated interventions such as organ transplants, care of preterm infants, cancer chemotherapy and hip replacements could turn out to be far more difficult or even to serious to undertake, according to Chan.
The new antibiotics being suggested today could help ward off catastrophe later. Nevertheless, drug makers are eager to supply drugs intended for short term use.
“It’s simply not profitable for them,” said Dr. William Schaffner, chairman of preventive medicine at Vanderbilt University Medical Center in Nashville. “If you create a new drug to reduce cholesterol, people will be taking that drug every day for the rest of their lives. But you only take antibiotics for a week or maybe 10 days.”
Schaffner suggests that while people try to encourage the pharmaceutical industry in making of new antibiotics, the way I see it, the expert would want people to be prudent.
Ciara Wilson, a full-time writer and a caring sibling, likes a convenient type of fireplace and a big swim spa to decorate in her extended living area alfresco. She feels more comfortable of having a warm-provider facility and a wonderful spa that brings fun to her family.
.
Leave Your Comments